Delivered-To: dominikfilipiuk@gmail.com
Received: by 2002:a25:4f41:0:0:0:0:0 with SMTP id d62csp3620786ybb;
        Tue, 25 Feb 2020 02:37:49 -0800 (PST)
X-Google-Smtp-Source: APXvYqwxb6SioiPyMLru+5jYm0w6K+bGJaJ8nNrM0bkivJQQ7igvyZgnlTvcbpXstFf/3rcrAOlr
X-Received: by 2002:a17:902:9890:: with SMTP id s16mr52829605plp.71.1582627068917;
        Tue, 25 Feb 2020 02:37:48 -0800 (PST)
ARC-Seal: i=1; a=rsa-sha256; t=1582627068; cv=none;
        d=google.com; s=arc-20160816;
        b=Cn1nBPINCQvj0OR8r74dV2m2H55E3iF4JKxt6VlTN8Y6JA39RowtP+vE/t6mIW+DaD
         GJMgAhjDBjyRS9+J1J6t8kRuSQIThHNxQlnHRHXiIhN19+47riy6AiYeanOcKx7Lg5B5
         1h3X+KxDbQltKvtlsAv+K+/nu2LoilaSYcDA4OA9z9iJGyPspjT3oUvmoHemXND2edAi
         2TXzSSTQ8ro4uSKvCgYgJDvoi2ikKqtO4yn+uqYZ/Z9LtIcad4pW/pfF5M1Nvm2R9U94
         ikgV1Dg02LC0ajiIskdGWug9Ku0e20sDZrqx+X5gng4eCHkzyefNoKSlMvPk4bV6nuAE
         55bQ==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20160816;
        h=content-transfer-encoding:mime-version:to:reply-to:from:subject
         :date:message-id:sender:dkim-signature;
        bh=4LZbm0KdYK7If1VDYLQpefi+slcMkAiI1kXobvIIBi0=;
        b=BdvV7Pa1NWSdl9vTexhiXrwMh3ufd+yCJ4quaCCIalray8BCvytWsG3HdmzlZbvAHM
         JIjGhtm8HbbEothNGg6EJKqTu6Xe4UIhNrXCuIxBtEV6E9Jb2RF5hlX2cjNKHiRZ9sUv
         oQn5aaSMuXDQYLGOJIUp421eKLaTXUgWTozocJmVzrtc5ioxDUw8rqaF4ZvtlE0q/cAE
         uECgKK7QVCF6OmW0Nr1q6giCVhd+Tv+UhdNzXgKrwRGRb9qn9A7tx2m9TawWiSYvzfVB
         dK3Z/Y2FslwbsGXEFNqCW9cSSTuwk1o3vX5yoKJ7uZWGKB/Vq7WjY9JC/vSDx/nrW8/n
         Yedw==
ARC-Authentication-Results: i=1; mx.google.com;
       dkim=pass header.i=@naturalsolutions.nz header.s=default header.b=iiLgB6n4;
       spf=pass (google.com: domain of sales@naturalsolutions.nz designates 103.16.181.137 as permitted sender) smtp.mailfrom=sales@naturalsolutions.nz
Return-Path: <sales@naturalsolutions.nz>
Received: from naturalsolutions.nz (mail.healthcentre.nz. [103.16.181.137])
        by mx.google.com with ESMTPS id q4si15704135pll.289.2020.02.25.02.37.48
        for <dominikfilipiuk@gmail.com>
        (version=TLS1_2 cipher=ECDHE-RSA-AES128-GCM-SHA256 bits=128/128);
        Tue, 25 Feb 2020 02:37:48 -0800 (PST)
Received-SPF: pass (google.com: domain of sales@naturalsolutions.nz designates 103.16.181.137 as permitted sender) client-ip=103.16.181.137;
Authentication-Results: mx.google.com;
       dkim=pass header.i=@naturalsolutions.nz header.s=default header.b=iiLgB6n4;
       spf=pass (google.com: domain of sales@naturalsolutions.nz designates 103.16.181.137 as permitted sender) smtp.mailfrom=sales@naturalsolutions.nz
Received: from naturalsolutions.nz (touchme.nz [103.16.181.137])
	by healthcentre.nz (Postfix) with ESMTPSA id C46B12CF40
	for <dominikfilipiuk@gmail.com>; Tue, 25 Feb 2020 23:37:44 +1300 (NZDT)
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=naturalsolutions.nz;
	s=default; t=1582627064;
	bh=4LZbm0KdYK7If1VDYLQpefi+slcMkAiI1kXobvIIBi0=; l=32145;
	h=Subject:From:To;
	b=iiLgB6n4kPtn9Hcp9k/65XbzoF3IMtF/o36oFJS9qCyi/W4o68SbBts6SfxKGAA/S
	 iM0IDi21Kuqowss13Ms/qGv5sk8u0oRnLDvp1Hn1xd22/Ij7RTpqWOcV4YQ9ziUsZ5
	 yCC87ffSGs0kbjxz/L9nQY3/YF6EhbMkiLdT8lfs=
Authentication-Results: healthcentre.nz;
        spf=pass (sender IP is 103.16.181.137) smtp.mailfrom=sales@naturalsolutions.nz smtp.helo=naturalsolutions.nz
Received-SPF: pass (healthcentre.nz: connection is authenticated)
Sender: Natural Solutions <sales@naturalsolutions.nz>
Message-ID: <4f67183c88d9eee5e42e656d86680954@naturalsolutions.nz>
Date: Tue, 25 Feb 2020 23:35:28 +1300
Subject: What is over a hundred times more effective than pure GcMAF ?
From: Natural Solutions <sales@naturalsolutions.nz>
Reply-To: Natural Solutions <sales@naturalsolutions.nz>
To: dominikfilipiuk@gmail.com
MIME-Version: 1.0
Content-Type: text/html; charset=utf-8
Content-Transfer-Encoding: quoted-printable

<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://w=
ww.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns=3D"http:=
//www.w3.org/1999/xhtml">
	<!-- start header --><!--
	convertInl=
ineCss =3D false;
	--><!-- end header -->
=09
<style type=
=3D"text/css">
body {=20
	font-family: Arial, Helvetica, sans-se=
rif;=20
	margin: 0;=20
	padding: 0;
}

table {
	b=
order-collapse: collapse;
	border-spacing: 0;
}

table=
.newsletter-pro-content td {

}

a.link,=20
a.lin=
k:link,=20
a.link:visited {=20
	border: none;=20
	color: #337ed0; =

	font-size: 12px;=20
	font-weight: bold;=20
	text-align: cent=
er;=20
	text-decoration: none;
	cursor: pointer;=20
	display:=
 block;=20
	line-height: 22px;=20
	width: 100%;=20
	height: 22px; =

}

a img {=20
	border: none; border-style: none;=20
}=

</style>

<style type=3D"text/css">
body {=20
	font=
-family: Arial, Helvetica, sans-serif;=20
	margin: 0;=20
	padding:=
 0;
}

table {
	border-collapse: collapse;
	borde=
r-spacing: 0;
}

table.newsletter-pro-content td {=


}

a.link,=20
a.link:link,=20
a.link:visited =
{=20
	border: none;=20
	color: #337ed0;=20
	font-size: 12p=
x;=20
	font-weight: bold;=20
	text-align: center;=20
	text-decor=
ation: none;
	cursor: pointer;=20
	display: block;=20
	line-h=
eight: 22px;=20
	width: 100%;=20
	height: 22px;=20
}

a=
 img {=20
	border: none; border-style: none;=20
}
</style=
>
<head>
		<meta http-equiv=3D"Content-Type" content=3D"text/htm=
l; charset=3Dutf-8" />
		<meta name=3D"viewport" content=3D"width=3D=
device-width, initial-scale=3D1, minimum-scale=3D1, maximum-scale=3D1"=
 />
		<title>What is over a hundred times more effective than pure Gc=
MAF ?</title>

		<style type=3D"text/css">
			* {
				f=
ont-family: Arial;
				font-size: 10pt;
				line-height: 1.2e=
m;
			}

			.ReadMsgBody {
				width: 100%;
		=
	}

			.ExternalClass {
				width: 100%;
	=
		}

			.ExternalClass, .ExternalClass p, .ExternalClass span,=
 .ExternalClass font, .ExternalClass td, .ExternalClass div {
				li=
ne-height: 100%;
			}

			@media only screen and (max-device=
-width: 480px), only screen and (max-width: 480px) {
				.np_resize_=
td_600,
				table[class=3D"table600"] {
					width: 300px !impo=
rtant;
				}
			=09
				.np_content_center {
					widt=
h: 280px !important;
					display: block !important;
					margin=
: auto;
				}
	=09
				.np_content_center_zero {
					wi=
dth: 100% !important;
				}

				.np_resize_600 {
					=
width: 300px !important;
					display: block !important;
					ma=
rgin: auto;
				}

				.np_hide {
					display: none =
!important;
				}

				.np_show_height15 {
					displ=
ay: block !important;
					width: 100% !important;
					height: =
15px !important;
				}

				.np_show_height10_color {=

					display: block !important;
					width: 100% !important=
;
					height: 10px !important;
					background-color: #383638 !i=
mportant;
				}

				.np_bg_color_black {
					backgrou=
nd-color: #383638 !important;
				}

				.np_color_white {=

					color: #ffffff !important;
				}

				.np_bg_co=
lor_white {
					background-color: #ffffff !important;
		=
		}
			=09
				.np_color_black {
					color: #383638 !import=
ant;
				}

				.np_show_height20 {
					display: blo=
ck !important;
					width: 100% !important;
					height: 20px !im=
portant;
				}

				.np_show_height15 {
					display:=
 block !important;
					width: 100% !important;
					height: 15px=
 !important;
				}

				.np_show_height25 {
					disp=
lay: block !important;
					width: 100% !important;
					height: =
25px !important;
				}

				.np_show_height30 {
					=
display: block !important;
					width: 100% !important;
					heig=
ht: 30px !important;
				}

				.np_content_padding {=

					width: 10px !important;
				}

				.np_content_p=
adding_zero {
					width: 0 !important;
				}

				.n=
p_height_10 {
					height: 10px !important;
				}

		=
		.np_logo {
					text-align: center !important;
				}
	=
		=09
				.np_logo img {
					display: inline !important;
	=
			}

				.np_header_date, .np_header_link {
					text-align=
: center !important;
				}

				.np_resize_image, .np_res=
ize_image img, .np_resize_image600 img {
					width: 100% !important=
;
					height: auto !important;
				}

				.np_resize=
_image600 {
					width: 300px !important;
					display: block !im=
portant;
					margin: auto;
				}

				.paragraph_res=
c {
					text-align: center !important;
				}

				.n=
p_width_100 {
					width: 100% !important;
				}

		=
		.np_min_height_auto {
					min-height: auto !important;
			=
	}
			}
		=09
			body {
				min-width: 0 !important=
;
			}
		</style>
	</head>
	<body style=3D"margin: 0; =
padding: 0; font-family: Arial; font-size: 10pt; line-height: 1.2em; col=
or: #666666; width:100%; min-width: 600px" bgcolor=3D"#4a4a4a"><table clas=
s=3D"newsletter-pro-container" width=3D"100%" border=3D"0" cellspacing=
=3D"0" cellpadding=3D"0" bgcolor=3D"#4a4a4a" style=3D"border-collapse: c=
ollapse;">
<tbody>
<tr>
<td align=3D"center">
<table cl=
ass=3D"table600" width=3D"600" border=3D"0" cellspacing=3D"0" cellpaddin=
g=3D"0" style=3D"border-collapse: collapse;">
<tbody>
<tr><!-- h=
eader bar -->
<td align=3D"left" bgcolor=3D"#55b82b">
<table wid=
th=3D"100%" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" style=3D"bord=
er-collapse: collapse;">
<tbody>
<tr>
<td align=3D"left" w=
idth=3D"20" class=3D"np_content_padding"></td>
<td align=3D"left" clas=
s=3D"np_content_center">
<table width=3D"100%" border=3D"0" cellspacin=
g=3D"0" cellpadding=3D"0" style=3D"border-collapse: collapse;">
<tbody=
>
<tr>
<td align=3D"left" style=3D"color: #ffffff; font-weight: =
bold;">February 25.2020</td>
<td align=3D"right" style=3D"color: #ff=
ffff;"><a href=3D"https://naturalsolutions.nz/modules/newsletterpro/newsle=
tter.php?&email=3Ddominikfilipiuk@gmail.com&token_tpl=3Dd0cbbaa577841dd7=
ef85217a0ab62fcf" style=3D"text-decoration: underline; color: #ffffff;">Vi=
ew online</a> / <a href=3D"https://naturalsolutions.nz/module/newsletterpr=
o/forward?email=3Ddominikfilipiuk@gmail.com&token=3De9c2e6d6b17ea46bde80=
50b863c79bf5" style=3D"text-decoration: underline; color: #ffffff;">Forwar=
d to friends</a></td>
</tr>
</tbody>
</table>
</td>=

<td align=3D"left" width=3D"20" class=3D"np_content_padding"></td=
>
</tr>
</tbody>
</table>
</td>
<!-- end header=
 bar --></tr>
<tr>
<td align=3D"left">
<table width=3D"100%"=
 border=3D"0" cellspacing=3D"0" cellpadding=3D"0" style=3D"border-collap=
se: collapse;" bgcolor=3D"#ffffff">
<tbody>
<tr>
<td align=
=3D"left" height=3D"20"></td>
</tr>
<tr><!-- logo bar -->=

<td align=3D"left">
<table width=3D"100%" border=3D"0" cellsp=
acing=3D"0" cellpadding=3D"0" style=3D"border-collapse: collapse;">
<t=
body>
<tr>
<td class=3D"np_resize_600" align=3D"left">
<tabl=
e width=3D"100%" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" style=3D=
"border-collapse: collapse;">
<tbody>
<tr>
<td width=3D"20=
" class=3D"np_content_padding"></td>
<td class=3D"np_content_center"=
 align=3D"left">
<table width=3D"100%" border=3D"0" cellspacing=3D"0=
" cellpadding=3D"0" style=3D"border-collapse: collapse;">
<tbody=
>
<tr>
<td class=3D"np_resize_image" align=3D"center" valign=
=3D"middle"><img src=3D"https://naturalsolutions.nz/img/natural-solution=
s-logo-1576400780.jpg" alt=3D"Natural Solutions" style=3D"display: block=
; max-height: 100px;" width=3D"243" height=3D"100" /></td>
</tr>=

</tbody>
</table>
</td>
<td width=3D"20" class=3D"n=
p_content_padding"></td>
</tr>
</tbody>
</table>
</td>=

</tr>
</tbody>
</table>
</td>
<!-- end logo bar -=
-></tr>
<tr>
<td align=3D"left" height=3D"40">
<div style=3D=
"text-align: center;"><span style=3D"color: #ff8c00; font-size: 24pt; font=
-weight: bold;">BREAKING NEWS</span></div>
<div style=3D"text-align: c=
enter;"><span style=3D"color: #55b82b; font-size: 24pt; font-weight: bold;=
">imuno<sup>=C2=AE</sup> proven to be over 100 times more effective than =
pure GcMAF</span></div>
<br />
<div style=3D"text-align: center=
; padding-left: 5px; padding-right: 5px; padding-bottom: 5px; font-weigh=
t: bold;">Scientists at R.E.D. Laboratories in Belgium have elucidated t=
he mechanism of action of GcMAF and proven that imuno<sup>=C2=AE</sup> is=
 over 100 times more potent than purified GcMAF.</div>
</td>
</t=
r>
<tr>
<td align=3D"left" height=3D"5" bgcolor=3D"#55b82b"></t=
d>
</tr>
</tbody>
</table>
</td>
</tr>
<!-- =
banner --> <!-- end banner -->
<tr>
<td align=3D"left">
<ta=
ble width=3D"100%" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" styl=
e=3D"border-collapse: collapse;" bgcolor=3D"#ffffff">
<tbody>
<t=
r>
<td align=3D"left" height=3D"25">
<table class=3D"clear-new=
sletter-template-products" border=3D"0" cellspacing=3D"0" cellpadding=3D"0=
" style=3D"margin: 0; padding: 0; border-collapse: collapse;">
<tbody>=

<tr>
<td class=3D"newsletter-products-container">
<table =
class=3D"np-responsive-table-container" border=3D"0" cellpadding=3D"0" cel=
lspacing=3D"0">
<tbody><!----------------BEGIN/END PRODUCT------------=
-------->
<tr>
<td height=3D"15"></td>
</tr>
<=
tr>
<td align=3D"left">
<table width=3D"100%" border=3D"0" cell=
spacing=3D"0" cellpadding=3D"0" style=3D"border-collapse: collapse=
;">
<tbody>
<tr class=3D"np-row-products-target">
<td align=
=3D"left">
<table data-id=3D"6" width=3D"100%" border=3D"0" cellspac=
ing=3D"0" cellpadding=3D"0" style=3D"border-collapse: collapse;" bgcol=
or=3D"#ffffff" class=3D"newsletter-pro-product">
<tbody>
<tr=
>
<td align=3D"left" width=3D"250" class=3D"np_resize_600" valign=3D=
"top" style=3D"position: relative;">
<table width=3D"100%" border=3D"0=
" cellspacing=3D"0" cellpadding=3D"0" style=3D"border-collapse: collapse;"=
>
<tbody>
<tr>
<td align=3D"left" height=3D"15"></td=
>
</tr>
<tr>
<td align=3D"left" class=3D"np_resize_image">=
<a href=3D"https://naturalsolutions.nz/imuno-3ml-vial?newsletterpro_source=
=3Dnewsletter&id_newsletter=3D3&SubmitCurrency=3Dyes&id_currency=3D1" ta=
rget=3D"_blank" style=3D"text-decoration: none; display: block;"> <img c=
lass=3D"newsletter-pro-image" src=3D"https://naturalsolutions.nz/253-lar=
ge_default/imuno-3ml-vial.jpg" width=3D"100%" style=3D"display: block;" =
alt=3D"" /> </a></td>
</tr>
</tbody>
</table>
</td>=

<td align=3D"center" class=3D"np_resize_600" valign=3D"top">
<=
table width=3D"100%" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" st=
yle=3D"border-collapse: collapse;">
<tbody>
<tr>
<td align=
=3D"left" class=3D"np_content_padding" width=3D"20"></td>
<td align=
=3D"left" class=3D"np_content_center" valign=3D"top">
<table width=3D=
"100%" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" style=3D"border-=
collapse: collapse; min-height: 225px;" class=3D"np_min_height_aut=
o">
<tbody>
<tr>
<td align=3D"left" valign=3D"top">
<t=
able width=3D"100%" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" sty=
le=3D"border-collapse: collapse;">
<tbody>
<tr>
<td align=3D=
"left" height=3D"15"></td>
</tr>
<tr>
<td align=3D"left">=
<a style=3D"color: #55b82b; text-decoration: none; font-size: 14pt;" h=
ref=3D"https://naturalsolutions.nz/imuno-3ml-vial?newsletterpro_source=
=3Dnewsletter&id_newsletter=3D3&SubmitCurrency=3Dyes&id_currency=3D1" ta=
rget=3D"_blank" class=3D"newsletter-pro-name"> imuno<sup>=C2=AE</sup> 3ml=
 vial :<br />GcMAF Made MUCH Better =E2=9C=85 </a></td>
</tr>
<tr=
>
<td align=3D"left" height=3D"15"></td>
</tr>
<tr><!-------=
------------------------------>
<td align=3D"left" class=3D"newslette=
r-pro-description_short">Each Vial Contains: 3ml, which equals 15 x 0.2m=
l servings.
<ul>
<li>Adult Serving Size with late stage Cancer=
: 0.2 ml (4 drops) once a day. (Vial will last approx 15 days at this ra=
te)<br /><br /></li>
<li>Child Serving Size with Autism: 0.01 ml onc=
e a week per 5 Kg (11 lbs) of body weight.</li>
</ul>
</t=
d>
</tr>
<tr>
<td align=3D"left" height=3D"15"></td>=

</tr>
</tbody>
</table>
</td>
</tr>
<=
tr>
<td align=3D"left" valign=3D"bottom">
<table width=3D"100%"=
 border=3D"0" cellspacing=3D"0" cellpadding=3D"0" style=3D"border-collap=
se: collapse;">
<tbody>
<tr>
<td align=3D"left">
<ta=
ble width=3D"100%" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" styl=
e=3D"border-collapse: collapse;">
<tbody>
<tr>
<td align=
=3D"left" valign=3D"middle"><span style=3D"color: #55b82b; font-size: 18pt=
; font-weight: bold;">US$650.00</span></td>
<td align=3D"right" val=
ign=3D"bottom">
<table border=3D"0" cellpadding=3D"0" cellspacing=3D=
"0" width=3D"65" bgcolor=3D"#55b82b" style=3D"border-collapse: collapse; f=
ont-weight: bold;">
<tbody>
<tr>
<td align=3D"center" valign=
=3D"middle" height=3D"20" bgcolor=3D"#55b82b"><a href=3D"https://natural=
solutions.nz/imuno-3ml-vial?newsletterpro_source=3Dnewsletter&id_newslette=
r=3D3&SubmitCurrency=3Dyes&id_currency=3D1" target=3D"_blank" style=3D"col=
or: #ffffff; text-decoration: none; font-size: 9pt;">VIEW</a></td>
<=
/tr>
</tbody>
</table>
</td>
</tr>
</tbody>
<=
/table>
</td>
</tr>
<tr>
<td align=3D"left" height=3D"=
15"></td>
</tr>
</tbody>
</table>
</td>
</t=
r>
</tbody>
</table>
</td>
<td align=3D"left" class=3D=
"np_content_padding" width=3D"20"></td>
</tr>
</tbody>
</tab=
le>
</td>
</tr>
</tbody>
</table>
</td>
</t=
r>
</tbody>
</table>
</td>
</tr>
<!---------------=
-BEGIN/END PRODUCT--------------------> <!-----------------------------E=
ND PRODUCT / BEGIN MESSAGE------------------------------------->
<tr=
>
<td align=3D"left" height=3D"40"><br />
<div style=3D"text-a=
lign: center;"><span style=3D"color: #55b82b; font-size: 16pt; font-weight=
: bold;">FREE World Wide Express Courier<br /></span></div>
</td>=

</tr>
<tr>
<td height=3D"15"></td>
</tr>
<!---=
-------------END MESSAGE--------------------></tbody>
</table>
<=
/td>
</tr>
</tbody>
</table>
</td>
</tr>
<=
tr>
<td align=3D"left">
<table width=3D"100%" border=3D"0" cell=
spacing=3D"0" cellpadding=3D"0" style=3D"border-collapse: collapse=
;">
<tbody>
<tr>
<td align=3D"left" width=3D"20" class=3D"np=
_content_padding"></td>
<td align=3D"left" class=3D"np_content_center=
"></td>
<td align=3D"left" width=3D"20" class=3D"np_content_padding=
"></td>
</tr>
</tbody>
</table>
</td>
</tr>
<=
/tbody>
</table>
</td>
</tr>
<!-- block products -=
->
<tr>
<td align=3D"center" class=3D"np-products-target"><span s=
tyle=3D"color: #ffffff;" class=3D"np-products-template-info-remove"><spa=
n style=3D"color: #ffffff;" class=3D"np-products-template-info-remov=
e">=C2=A0<br /></span></span></td>
</tr>
<!-- end block produc=
ts --> <!-- block text --> <!-- text block --> <!-----------------------=
------------------------------------------------------------------------=
--->
<tr>
<td align=3D"left">
<table width=3D"100%" borde=
r=3D"0" cellspacing=3D"0" cellpadding=3D"0" style=3D"border-collapse: co=
llapse;" bgcolor=3D"#ffffff">
<tbody>
<tr>
<td align=3D"le=
ft" height=3D"5" bgcolor=3D"#55b82b"></td>
</tr>
<tr>
<td al=
ign=3D"left" height=3D"15"></td>
</tr>
<tr>
<td align=3D"le=
ft">
<table width=3D"100%" border=3D"0" cellspacing=3D"0" cellpadd=
ing=3D"0" style=3D"border-collapse: collapse;">
<tbody>
<=
tr>
<td align=3D"left" width=3D"20" class=3D"np_content_padding"></=
td>
<td align=3D"left" class=3D"np_content_center">
<table wi=
dth=3D"100%" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" style=3D"bor=
der-collapse: collapse;">
<tbody>
<tr>
<td align=3D"center=
" style=3D"font-size: 16pt; color: #55b82b;">imuno<sup>=C2=AE</sup> =3D G=
cMAF Made MUCH Better<br /><br /></td>
</tr>
<tr>
<td al=
ign=3D"left"><img class=3D"newsletter-pro-image" src=3D"https://naturalsol=
utions.nz/images/imuno-GcMAF-Nagalase-960x542.jpg" width=3D"100%" styl=
e=3D"display: block;" alt=3D"imuno is 100 times more potent than GcMAF" =
/>
<div style=3D"padding-left: 5px; padding-right: 5px; padding-bottom=
: 5px;">
<p align=3D"left" style=3D"margin-bottom: 0cm; line-height:=
 100%;"><span face=3D"Arial, sans-serif" style=3D"font-family: Arial, sa=
ns-serif;"><i>19<sup>th</sup> February 2020: Dr Marco Ruggiero, MD. PhD.=
</i></span></p>
<p align=3D"left" style=3D"margin-bottom: 0cm; line-h=
eight: 100%;"><span face=3D"Arial, sans-serif" style=3D"font-family: Ari=
al, sans-serif;">Elevated serum alpha-N-acetylgalactosaminidase (nagalas=
e) is associated with a number of life threatening and/or debilitating c=
onditions ranging from cancer <i>(Korbelik et al., 1998; Greco et al., 2=
009; Thyer et al., 2013)</i> to viral infections caused by influenza vir=
us and HIV <i>(Yamamoto and Urade, 2005; Yamamoto, 2006)</i>, bacterial =
infections <i>(Caines et al., 2008)</i>, alcoholism <i>(Zoga et al., 201=
7)</i>, and autism <i>(Bradstreet et al., 2012)</i>. Nagalase, an enzyme=
, was first proposed as a marker for cancer and viral infections and its=
 increased serum activity in these conditions was associated with immune=
 system deficiency because nagalase prevents formation of the Gc protein=
 derived Macrophage Activating Factor (GcMAF), an immune stimulant cytok=
ine <i>(Yamamoto and Naraparaju, 1997; Yamamoto and Urade, 2005; Yamamot=
o, 2006)</i>. According to the original hypothesis proposed by Yamamoto =
and Colleagues, cancer cells and cells infected by viruses produced and =
released nagalase that caused immune deficiency that, in turn, favored t=
he progression of cancer or viral infections. Therefore, elevated serum =
nagalase activity in cancer and viral infections was considered a conseq=
uence of cancer or viral-infected cells releasing nagalase. In apparent =
agreement with this hypothesis, successful immunotherapy of cancer with =
GcMAF was associated with a decrease of serum nagalase activity <i>(Thye=
r et al., 2013; Schwalb et al., 2016)</i> that was attributed to the eff=
ects of GcMAF on macrophages that, once activated, attacked cancer cells=
 with consequent decrease of the number of cancer cells producing nagala=
se. </span></p>
<!------------------------------->
<p align=3D"=
left" style=3D"margin-bottom: 0cm; line-height: 100%;"><span face=3D"Ari=
al, sans-serif" style=3D"font-family: Arial, sans-serif;">This interpretat=
ion, however, was contradicted by the observation that in autism, just l=
ike in cancer, successful immunotherapy with GcMAF was associated with s=
ignificant decrease of serum nagalase activity <i>(Bradstreet et al., 20=
12)</i>. Since the autistic subjects successfully treated with GcMAF had=
 no signs of cancer cells producing nagalase, nor of any other concurren=
t disease or infections <i>(Bradstreet et al., 2012)</i>, a novel hypoth=
esis concerning the role of nagalase was proposed. According to this nov=
el hypothesis, elevated nagalase activity has to be considered more a pa=
thogenetic factor for cancer and other conditions rather than a simple m=
arker. In simpler words, elevated nagalase activity may be one of the ca=
usative factors leading to cancer, autism or other diseases because elev=
ated nagalase impairs the function of the immune system and immune defic=
iency plays a pivotal role in the onset and development of cancer and ot=
her diseases. Such a role for nagalase is now well established as exempl=
ified by the title of a recent review that reads " Is =CE=B1-N-acetylgala=
ctosaminidase the key to curing cancer?" <i>(Saburi et al., 2017a)</i>. =
Based on these considerations, strategies aiming at reducing serum nagal=
ase activity may prove useful in the fight against cancer, autism, viral=
 infections and all other conditions associated with elevated serum naga=
lase activity.</span></p>
<!------------------------------->
<p =
align=3D"left" style=3D"margin-bottom: 0cm; line-height: 100%;"><span fa=
ce=3D"Arial, sans-serif" style=3D"font-family: Arial, sans-serif; font-w=
eight: bold;">Here we demonstrated for the first time that GcMAF directl=
y binds to, and inhibits, human nagalase <i>in vitro</i>, thus elucidati=
ng the mechanism of action of GcMAF and explaining its effectiveness in =
a variety of conditions ranging from cancer to autism <i>(Saburi et al.,=
 2017a; Saburi et al., 2017b; Bradstreet et al., 2012; Greilberger and H=
erwig, 2020)</i>. In addition, we demonstrate that a novel supplement co=
ntaining low-molecular-weight microbial chondroitin sulfate, ultrapure p=
hosphatidylcholine, and vitamin D3, (imuno=C2=AE, imuno Corporation, Vanu=
atu) shows more than 100 fold higher activity than purified GcMAF.</span=
></p>
<!------------------------------->
<p align=3D"left" sty=
le=3D"margin-bottom: 0cm; line-height: 100%;"><span face=3D"Arial, sans-=
serif" style=3D"font-family: Arial, sans-serif;">Human nagalase and GcMAF =
were purified at R.E.D. Laboratories (Zellik, Belgium). The experiment w=
as performed using microtiter plates coated with a specific antibody abl=
e to capture human nagalase. Samples were incubated with a standardized =
dilution of a pool of 300 human sera from healthy subjects and, after 1 =
h incubation and exhaustive washing, nagalase-GcMAF or nagalase-imun=
o=C2=AE complexes were detected with a horse radish peroxidase conjugate =
of a rabbit antibody. In order to establish the kinetics of interaction =
between nagalase and GcMAF, or imuno=C2=AE, the serum pool was mixed eith=
er with 200 ng of purified Gc-MAF, or with a 1:100 dilution of imuno=
=C2=AE in phosphate buffered saline (PBS). Since preliminary experiments =
indicated that undiluted imuno=C2=AE exceeded the binding capacity of nag=
alase in the test, imuno=C2=AE was diluted 1:100 in PBS. The mixture was =
then incubated at room temperature for 4, 24, 48, 72 and 120 h. Values f=
or nagalase binding activity in the absence of GcMAF or imuno=C2=AE, with=
 only PBS in the reaction mixture, were taken as 1.00. The experiment wa=
s repeated twice and the results reported in Fig. 1 are the means of the=
 two experiments.</span></p>
<!------------------------------->
<=
p align=3D"left" style=3D"margin-bottom: 0cm; line-height: 100%;"><span =
face=3D"Arial, sans-serif" style=3D"font-family: Arial, sans-serif;">As =
shown in Fig. 1, purified GcMAF bound human nagalase only after 4 h incu=
bation, reached a peak at 48 h, and returned below baseline values at 12=
0 h. imuno=C2=AE, on the other hand, had an initial value (at 0 h) higher=
 than PBS, thus demonstrating immediate, intrinsic GcMAF activity agains=
t human nagalase. At every time point, imuno=C2=AE showed significantly h=
igher activity in comparison with purified GcMAF and, at 120 h, imun=
o=C2=AE activity was still well above baseline, thus indicating a stronge=
r, more prolonged activity. It is worth noticing that imuno=C2=AE was dil=
uted 100 fold and, therefore, it may be argued that its activity against=
 human nagalase is more than 100 fold higher than that of purified GcMAF=
.</span></p>
<!------------------------------->
<p align=3D"lef=
t" style=3D"margin-bottom: 0cm; line-height: 100%;"><span face=3D"Arial,=
 sans-serif" style=3D"font-family: Arial, sans-serif;">It is also importan=
t to consider that these results were obtained <i>in vitro</i>, that is =
in the absence of any variable or confounding factor that may hamper int=
erpretation of results observed in clinical settings. Direct interaction=
 between imuno=C2=AE and nagalase may help explaining the effectiveness o=
f imuno=C2=AE recently observed by Antonucci and Colleagues in those cond=
itions where GcMAF had proven effective in the past <i>(Antonucci et al.=
, 2019a; Antonucci et al., 2019b)</i> and lead to propose imuno=C2=AE as =
a more potent and intrinsically safer substitute for human-blood-derived=
 GcMAF. The significantly higher potency of imuno=C2=AE is to be ascribed=
 to its peculiar molecular design that was described in detail in two re=
cent papers <i>(Ruggiero and Pacini, 2018a; Ruggiero and Pacini, 2018b)<=
/i>; in brief, imuno=C2=AE reproduces that physical-chemical features of =
GcMAF at a much higher molecular efficiency and density. The N-acetylgal=
actosamine active site of GcMAF is present in much higher concentration =
in imuno=C2=AE thanks to the presence of low-molecular-weight chondroitin=
 sulfate, a sulfated polysaccharide that is composed by an alternating c=
hain of Nacetylgalactosamine and glucuronic acid. The hydrophobic moieti=
es of GcMAF, that are the regions binding vitamin D and fatty acids, are=
 present in imuno=C2=AE thanks to the binding of phosphatidylcholine to c=
hondroitin sulfate. Vitamin D3, essential for increasing the potency of =
GcMAF as demonstrated by Greilberger and Herwig in 2020, is intercalated=
 in the proto-cellular structure formed by the core of chondroitin sulfa=
te surrounded by phosphatidylcholine <i>(Ruggiero and Pacini, 2018a)</i>=
. In fact, imuno=C2=AE was designed taking into account the physical-chem=
ical features of GcMAF that were published 2013 when a molecular model o=
f GcMAF interaction with the cell membrane was described <i>(Thyer et al=
., 2013)</i>. In this model, optimal interaction was achieved when GcMAF=
 was non-covalently bound to a fatty acid - in that example, oleic acid =
- and vitamin D3 that are the conditions reproduced, at a much higher mo=
lecular efficiency and density, in imuno=C2=AE.</span></p>
</div>=

<!-----------------------------------------------------------------=
------------------------> <!--<p><b>NOTE:</b><br />Promotion valid until=
 the 31st of July 2019, and not=C2=A0necessarily valid in conjunction wit=
h other promotions, discounts or vouchers.</p>--> <!--------------------=
-------------------------------------------------></td>
</tr>
</t=
body>
</table>
</td>
<td align=3D"left" width=3D"20" cla=
ss=3D"np_content_padding"></td>
</tr>
</tbody>
</tab=
le>
</td>
</tr>
<tr>
<td align=3D"left" height=3D"15">=
</td>
</tr>
<tr>
<td align=3D"left" height=3D"2" bgcolor=3D"=
#2e2e2e"></td>
</tr>
</tbody>
</table>
</td>
</t=
r>
<!-- end text block --> <!---------------------------------------=
----------------------------------------------------------> <!-- end tex=
t block -->
<tr>
<td height=3D"15"></td>
</tr>
<=
tr>
<td align=3D"left"><!-- block footer -->
<table width=3D"100%=
" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" style=3D"border-colla=
pse: collapse;" bgcolor=3D"#55b82b">
<tbody>
<tr>
<td align=
=3D"left" height=3D"20"></td>
</tr>
<tr>
<td align=3D"left">=

<table width=3D"100%" border=3D"0" cellspacing=3D"0" cellpadding=3D=
"0" style=3D"border-collapse: collapse;">
<tbody>
<tr>
<td a=
lign=3D"left" class=3D"np_resize_600" width=3D"300" valign=3D"top">
<=
table width=3D"100%" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" st=
yle=3D"border-collapse: collapse;">
<tbody>
<tr>
<td align=
=3D"left" width=3D"20" class=3D"np_hide"></td>
<td align=3D"left" cl=
ass=3D"np_content_center">
<table width=3D"100%" border=3D"0" cellspac=
ing=3D"0" cellpadding=3D"0" style=3D"border-collapse: collapse;">
<=
tbody>
<tr>
<td align=3D"left" valign=3D"top" width=3D"50%"=
>
<table width=3D"100%" border=3D"0" cellspacing=3D"0" cellpadding=
=3D"0" style=3D"border-collapse: collapse;">
<tbody>
<tr>
<t=
d align=3D"left" style=3D"color: #ffffff;">INFORMATION</td>
</tr>=

<tr>
<td height=3D"10"></td>
</tr>
<tr>
<td><a=
 href=3D"https://naturalsolutions.nz/new-products" target=3D"_blank" sty=
le=3D"color: #ffffff; text-decoration: none;">New products</a></td>
</=
tr>
<tr>
<td><a href=3D"https://naturalsolutions.nz/best-sales" =
target=3D"_blank" style=3D"color: #ffffff; text-decoration: none;">Best =
sales</a></td>
</tr>
<tr>
<td><a href=3D"https://naturalso=
lutions.nz/contact-us" target=3D"_blank" style=3D"color: #ffffff; text-d=
ecoration: none;">Contact us</a></td>
</tr>
<tr>
<td><a hr=
ef=3D"https://naturalsolutions.nz/sitemap" target=3D"_blank" style=3D"colo=
r: #ffffff; text-decoration: none;">Sitemap</a></td>
</tr>
</tbo=
dy>
</table>
</td>
<td align=3D"left" valign=3D"top" width=
=3D"50%">
<table width=3D"100%" border=3D"0" cellspacing=3D"0" cellpa=
dding=3D"0" style=3D"border-collapse: collapse;">
<tbody>
<t=
r>
<td align=3D"left" style=3D"color: #ffffff;">MY ACCOUNT</td>
<=
/tr>
<tr>
<td height=3D"10"></td>
</tr>
<tr>
<t=
d><a href=3D"https://naturalsolutions.nz/order-history" target=3D"_blank=
" style=3D"color: #ffffff; text-decoration: none;">My orders</a></=
td>
</tr>
<tr>
<td><a href=3D"https://naturalsolutions.nz/c=
redit-slip" target=3D"_blank" style=3D"color: #ffffff; text-decoration: =
none;">My credit slips</a></td>
</tr>
<tr>
<td><a href=3D"h=
ttps://naturalsolutions.nz/addresses" target=3D"_blank" style=3D"color: =
#ffffff; text-decoration: none;">My addresses</a></td>
</tr>
<tr=
>
<td><a href=3D"https://naturalsolutions.nz/identity" target=3D"_bl=
ank" style=3D"color: #ffffff; text-decoration: none;">My personal info</a>=
</td>
</tr>
<tr>
<td><a href=3D"https://naturalsolutions.nz/=
discount" target=3D"_blank" style=3D"color: #ffffff; text-decoration: no=
ne;">My vouchers</a></td>
</tr>
</tbody>
</table>
</td>=

</tr>
</tbody>
</table>
</td>
</tr>
</tbo=
dy>
</table>
</td>
<td height=3D"15" class=3D"np_show_heig=
ht15"></td>
<td align=3D"left" class=3D"np_resize_600" width=3D"300=
" valign=3D"top">
<table width=3D"100%" border=3D"0" cellspacing=3D"0=
" cellpadding=3D"0" style=3D"border-collapse: collapse;">
<tbody=
>
<tr>
<td align=3D"left" class=3D"np_content_center">
<tabl=
e width=3D"100%" border=3D"0" cellspacing=3D"0" cellpadding=3D"0" style=3D=
"border-collapse: collapse;">
<tbody>
<tr>
<td align=3D"le=
ft" valign=3D"top" width=3D"50%">
<table width=3D"100%" border=3D"0"=
 cellspacing=3D"0" cellpadding=3D"0" style=3D"color: #ffffff;">
<tbody=
>
<tr>
<td align=3D"left" style=3D"color: #ffffff;">CONTACT</td>=

</tr>
<tr>
<td height=3D"10"></td>
</tr>
<=
tr>
<td style=3D"color: #ffffff;">Natural Solutions NZ</td>
</t=
r>
<tr>
<td style=3D"color: #ffffff;">40 St Benedicts Street</t=
d>
</tr>
<tr>
<td style=3D"color: #ffffff;">Auckland, New =
Zealand</td>
</tr>
</tbody>
</table>
</td>
<td ali=
gn=3D"left" valign=3D"top" width=3D"50%">
<table width=3D"100%" borde=
r=3D"0" cellspacing=3D"0" cellpadding=3D"0" style=3D"border-collapse: co=
llapse;">
<tbody>
<tr>
<td align=3D"left" style=3D"color: #f=
fffff;"><!--FOLLOW US--></td>
</tr>
<tr>
<td height=3D"10"><=
/td>
</tr>
<tr>
<td><!--<a href=3D"https://www.facebook.com=
/naturalsolutionsnz/" target=3D"_blank" style=3D"color: #ffffff; text-de=
coration: none;">Facebook</a>--></td>
</tr>
<tr>
<td></td>=

</tr>
<tr>
<td></td>
</tr>
<tr>
<td></td>=

</tr>
</tbody>
</table>
</td>
</tr>
</tbo=
dy>
</table>
</td>
<td align=3D"left" width=3D"20" class=3D"=
np_hide"></td>
</tr>
</tbody>
</table>
</td>
</t=
r>
</tbody>
</table>
</td>
</tr>
<tr>
<td a=
lign=3D"left" height=3D"15"></td>
</tr>
<tr>
<td align=3D"ce=
nter" style=3D"color: #ffffff;"><a href=3D"https://naturalsolutions.nz/m=
odule/newsletterpro/unsubscribe?email=3Ddominikfilipiuk@gmail.com&u_to=
ken=3De9c2e6d6b17ea46bde8050b863c79bf5&msg=3D1&token=3Dd0cbbaa577841dd7ef8=
5217a0ab62fcf" target=3D"_blank" style=3D"text-decoration: underline; co=
lor: #ffffff;">Unsubscribe</a> from this newsletter instantly.</td>
<=
/tr>
<tr>
<td align=3D"left" height=3D"15"></td>
</t=
r>
</tbody>
</table>
<!-- end block footer --></td>
</=
tr>
</tbody>
</table>
</td>
</tr>
</tbody>
<=
/table><img style=3D"display: none; margin: 0; padding: 0; float: left; po=
sition: absolute;" src=3D"https://naturalsolutions.nz/modules/newsletterpr=
o/opened_email.php?email=3Ddominikfilipiuk@gmail.com&token=3Dd0cbbaa5778=
41dd7ef85217a0ab62fcf" height=3D"1" width=3D"1" data-embed=3D"0"/></bo=
dy>
</html>
